Carl Zeiss Meditec AG ( ETR:AFX ) shareholders should be happy to see the share price up 21% in the last month.

Carl Zeiss Meditec AG / Preliminary announcement on the disclosure of financial statements 05.02.2025 / 09:00 CET/CEST Preliminary announcement of the publication of quarterly reports and quarterly ...

Goldman Sachs has upgraded Carl Zeiss Meditec AG (ETR: AFXG) to 'neutral' from its previous 'sell' rating, signaling a shift ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

On Wednesday, Goldman Sachs analyst Richard Felton upgraded Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY), a medical technology company with a $5.2 billion market cap, from Sell to Neutral and ...

Goldman Sachs analyst Richard Felton upgraded Carl Zeiss Meditec AG (AFX:GR) (OTC: CZMWY), a medical technology company with a $5.2 billion market cap, from Sell to Neutral and increased the price ...

Carl Zeiss Meditec AG and its affiliates to not have clinical evidence supporting the opinions and statements of the health care professionals nor accept any responsibility or liability of the ...

Favorable industrywide trends, such as the aging population, an increasing prevalence of myopia, and a growing access to advanced healthcare across the globe, will act as tailwinds for Zeiss.